The new facility combines advanced technology, enhanced capacity, and holistic care, reaffirming HCG’s commitment to accessible, world-class oncology in Gujarat
USFDA inspection at Alembic Pharma's Bioequivalence facility
The company will take all necessary steps to work with USFDA towards earliest remediation of the above facility
The company will closely work with the USFDA to address and respond to the observations in an expeditious manner
Chlorpromazine Hydrochloride Injection is used to treat certain mental/mood disorders
ANVISA issues CGMP to Concord Biotech’s Unit I
BHL will undertake the development and supply of these molecules
Sugammadex Injection is indicated for the reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide
The company has received the Establishment Inspection Report (EIR) from the USFDA for the Pre-Approval Inspection (PAI) at a manufacturing site situated at Savli, Vadodara, Gujarat, with Zero 483 observations
The offer for sale comprises of up to Rs. 383 crore by Vishal Rakesh Agrawal, up to Rs. 383 crore by Rahul Rakesh Agrawal, and up to Rs. 134 crore by Geetganga Investment
Subscribe To Our Newsletter & Stay Updated
